Regeneron Pharmaceuticals
Regeneron is seeking a Process Development Engineer II to join the Preclinical Manufacturing & Process Development group, focusing on the Synthetic and Bioconjugation Scale-up Technologies team. The role involves developing conjugation and purification processes for bioconjugation of proteins, applying Quality by Design principles, and supporting process scale-up and technology transfer to manufacturing facilities. This position contributes to timely and reliable progress from clinic to commercialization within a science-driven organization.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Research Associate/Scientist I
ImmunEdge, Inc
Bioconjugation Process Development and Manufacturing Lead
Telix Pharmaceuticals
Senior Scientist, CMC Downstream Process Development
Neurocrine Biosciences
Scientist, Bioconjugation
Dyne Therapeutics
Senior Research Associate / Associate Scientist – Protein Sciences
ImmunEdge, Inc
TEMP - Scientist, Bioconjugation Purification
Neurocrine Biosciences